Spine surgeon steps down as CEO of biologics company


Kingsley Chin, MD, is stepping down as CEO of NanoFuse Biologics following the company's merger into a newly formed medtech company.

NanoFuse Biologics, Inspan and Sacrix merged into Nanisx to push minimally invasive spine technologies. A CEO for Nanisx is expected to be announced in the near future.

NanoFuse Biologics focuses on bone healing and fusion with a fiber-based bioactive glass combined with a demineralized bone matrix. The company merged to form Nanisx to help build its team and expand its market share in orthobiologics.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers